This inventor holds 32 USPTO granted patents, primarily in Beta-Lactam Derivatives. Top assignees: Farmitalia Carlo Erba, Farmitalia Carlo Erba S.r.l., Pharmacia & Upjohn. Active years: 1979-2004.
Location History:
- Bresso, IT (1979 - 1983)
- Boffalora Ticino, IT (1991 - 1998)
- Milan, IT (1986 - 2004)
Company Filing History:
13 out of 208Â 
12 out of 140Â 
3 out of 117Â 
Years Active: 1979-2004
Areas of Expertise:
Title: **Ettore Perrone: Innovator in Matrix Metalloproteinase Inhibition**
Introduction
Ettore Perrone, an accomplished inventor hailing from Boffalora Ticino, Italy, has made significant contributions to the field of pharmaceutical innovations. With an impressive portfolio of 32 patents, Perrone's work focuses on developing compounds with therapeutic applications in the treatment of diseases mediated by matrix metalloproteinases (MMPs).
Latest Patents
Among his latest innovations, Perrone has developed 3-arylsulfonyl-2 (substituted methyl) propanoic acid derivatives, which serve as potent matrix metalloproteinase inhibitors. These compounds feature a unique chemical structure, allowing for selective inhibition against MMPs, thereby aiding in the prevention and treatment of related diseases. Additionally, he's innovated amine derivatives that effectively inhibit matrix metalloproteinases and the release of tumor necrosis factor-alpha (TNF), offering potential solutions for tumoral and inflammatory diseases.
Career Highlights
Perrone's extensive career includes noteworthy roles in leading companies such as Farmitalia Carlo Erba S.r.l. and Farmitalia Carlo Erba S.p.a. His work in these organizations has played a crucial role in advancing the field of pharmaceutical chemistry and has contributed to the development of various medical therapies.
Collaborations
Throughout his career, Ettore Perrone has collaborated with distinguished colleagues, including Marco Alpegiani and Giovanni Franceschi. Their collective expertise has fostered a rich environment for innovation, enhancing the development of effective therapeutic agents.
Conclusion
Ettore Perrone's innovative spirit and dedication to scientific research highlight his importance in the pharmaceutical industry. His numerous patents not only reflect his ingenuity but also demonstrate the potential impact of his work in combating diseases linked to matrix metalloproteinases. As his career progresses, Perrone remains a significant figure in the realms of innovation and invention.